Press releases
Your source for Evernorth news.
Evernorth announces another step forward in lowering drug prices by making a Stelara biosimilar available at $0 out of pocket for patients early next year
Estimated to save individual Accredo patients around $4,000 per year
Biosimilar price will be more than 80% lower than Stelara list price
Accredo patients benefit from the specialty pharmacy’s best-in-class clinical support
Close search filters
Changing filters will change the listed Success Criteria and Techniques
Search results (50)
Press Release
Express Scripts Further Advances Transparency and Affordability for Consumers and Clients
April 13, 2023
Express Scripts, the pharmacy benefits management business of Evernorth, a subsidiary of The Cigna Group (NYSE: CI), today announced several actions to further evolve its pharmacy benefit management (PBM) model.
Press Release
Evernorth Health Services Expands Family Planning Benefits to Support Growing Families through Fertility, Pregnancy and Postpartum Journeys
March 23, 2023
Evernorth is expanding its FamilyPath suite of family-building benefits to support members throughout their fertility, pregnancy and postpartum journeys.
Press Release
MDLIVE Announces Evolution of Virtual Primary Care To Improve Health Outcomes for Patients with Chronic Conditions
November 14, 2022
New program uses remote vital monitoring and real-time reporting to give doctors unparalleled insights into their patients’ health between appointments – forging lasting relationships between doctors and patients and allowing earlier interventions.
Enhancement comes as MDLIVE primary care visits grew by more than 300% last year.
Press Release
Evernorth Enters Strategic Collaboration with VillageMD to Accelerate Value-Based Services and Care Delivery Strategy
November 07, 2022
Press Release
Express Scripts Announces Strategic Partnership with Centene to Unlock Greater Prescription Drug Savings
October 25, 2022